Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Biorem Inc V.BRM

Alternate Symbol(s):  BIRMF

Biorem Inc. is a Canada-based clean technology company. The Company designs, manufactures and distributes a line of air emissions control systems used to eliminate odors, volatile organic compounds (VOCs) and hazardous air pollutants (HAPs). It operates through one reportable segment, which involves the manufacture and sale of pollution control systems. Its solutions include BASYS and BiofiltAIR biofilter, MYTILUS biotrickling filter, multi-stage SYNERGY system, biogas desulfurization, dry scrubber adsorption systems and cannabis odor control. Its BASYS and BiofiltAIR biofilter systems are suited for odor control applications, especially when removing reduced sulfur compounds or VOCs. It offers biofiltration medias, which include BIOSORBENS, XLD, BIOPAK and BIOROLL & BIOBLOK. The Company's service solutions include system upgrades, preventative maintenance, and replacement and spare parts. Its other services dispersion modeling, permit applications and community outreach programs.


TSXV:BRM - Post by User

Bullboard Posts
Comment by KnowledgeSeekr8on Dec 13, 2017 8:41am
51 Views
Post# 27144844

RE:Great News.. $7 million in New Contracts ..China Ramping up

RE:Great News.. $7 million in New Contracts ..China Ramping upGreat news, especially that this work is also in China! I did a quick calculation of there previously being $21 mil in backlog at the end of Q3 and now being $17 mil along with the $7 mil in new orders. That would equate to $11 mil in revenue. Does that make sense? If so, its going to be a record Q4 and nearly 70% in one quarter that Biorem did in all of 2016!
Bullboard Posts